Newsletter
Massachusetts voters reject cannabis legalization rollback measure (Newsletter: November 4, 2026)
Houston deprioritizes marijuana arrests; ID anti-cannabis amendment fails; Poll: 280E tax savings should lower prices; Cannabis medicine op-ed
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
By starting a $10 per month pledge on Patreon—or about 45 cents per issue of this newsletter—you can help us rely less on ads to cover our expenses, hire more journalists and bring you even more marijuana news.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Massachusetts voters rejected a ballot initiative to roll back the state’s marijuana legalization law—opting to keep recreational cannabis sales legal.
Idaho voters defeated a proposed constitutional amendment that would have prevented them from ever being able to legalize marijuana or other drugs for medical or recreational purposes in future elections.
Voters in Houston, Texas approved a ballot measure to make misdemeanor marijuana possession the “lowest possible enforcement priority” for local police while also banning no-knock warrants.
The Massachusetts Senate Ways and Means Committee approved a House-passed bill to let military veterans get medical cannabis recommendations without doctors’ recommendations—and to add PTSD, opioid use disorder and chronic pain as qualifying conditions.
A new poll shows that three out of four marijuana consumers expect cannabis businesses to lower product prices as they get tax relief from the federal 280E penalty under the Trump administration’s rescheduling move.
Matthew Myro Rothman of EM2P2 and CannaLnx argues in a new Marijuana Moment op-ed that the growing legitimacy of cannabis as a medicine raises questions about “who gets to decide what cannabinoid healthcare looks like from here.”
- “Cannabis could finally achieve the legitimacy the industry spent decades pursuing while much of the knowledge that built medical cannabis remains fragmented, underdocumented or pushed aside… Becoming a credible healthcare category does not require whole-plant cannabinoid medicine to become indistinguishable from conventional pharmaceuticals.”
/ FEDERAL
The Substance Abuse and Mental Health Services Administration tweeted, “Secondhand marijuana smoke can affect people nearby. Understanding the risks can help you make informed decisions and protect those around you.”
/ STATES
Vermont regulators approved changes to various cannabis rules.
Illinois officials included cannabis-related offenses as disqualifications in healthcare worker background check rules.
Georgia regulators are increasing the cost of medical cannabis patient and caregiver cards.
California officials touted enforcement actions against illicit cannabis and tobacco operations.
Michigan regulators published a monthly report on disciplinary actions against marijuana businesses.
Washington, D.C. officials touted enforcement action against a business accused of illegal cannabis and psilocybin sales.
Montana regulators sent a newsletter with various cannabis updates.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ SCIENCE & HEALTH
A study found that “there were significant associated decreases in total Part 1 crime and total property crime in dispensary census tracts relative to control tracts, after dispensaries were allowed to sell recreational marijuana.”
A review concluded that “psilocybin administered with structured psychological support shows short-term antidepressant activity in carefully selected adults with” treatment-resistant depression.
/ BUSINESS
Organigram Global Inc. is acquiring Aurora Cannabis Inc.
Curaleaf Holdings, Inc. reported quarterly net revenue of $352.7 million and a net loss of $32.7 million.
Innovative Industrial Properties, Inc. reported quarterly revenue of $64.9 million.
Tilray Brands, Inc. is moving to consolidate its Canadian cannabis operations.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
